Nevertheless, ingestion of low-dose IFNα preserved β-cell function in recent-onset T1D patients (66), and additional clinical trials have since shown protective effects of ingested IFNα in patients suffering from MS (67). The gene discussed is IFNA1; the disease is type 1 diabetes mellitus.